Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Original Research

Published on 20 Sep 2024

Adverse event profile differences between pralsetinib and selpercatinib: a real-world study based on the FDA adverse events reporting system

in Pharmacology of Anti-Cancer Drugs

Qiong Jie
Yuanyuan Li
Li Jing
Jinjin Chen
Yang Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1424980

2,557 views
3 citations

Systematic Review

Published on 18 Sep 2024

Efficacy and safety of PARP inhibitor maintenance therapy for ovarian cancer: a meta-analysis and trial sequential analysis of randomized controlled trials

in Pharmacology of Anti-Cancer Drugs

Guojuan Sun
Yi Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1460285

2,488 views
3 citations

Original Research

Published on 17 Sep 2024

Extrachromosomal circular DNAs in prostate adenocarcinoma: global characterizations and a novel prediction model

in Pharmacology of Anti-Cancer Drugs

Qingliu He
Qingfu Su
Chengcheng Wei
Pu Zhang
Weihui Liu
Junyi Chen
Xiaoping Su
Wei Zhuang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1464145

1,894 views

Original Research

Published on 16 Sep 2024

Integrated analyses reveal IDO1 as a prognostic biomarker coexpressed with PD-1 on tumor-associated macrophages in esophageal squamous cell carcinoma

in Pharmacology of Anti-Cancer Drugs

Yaojun Peng
Lingxiong Wang
Juan Yang
Qiyan Wu
Xiaoxuan Sun
Jinying Zhang
Yanju Yu
Liping Zhang
Jie Gao
Qing Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1466779

2,023 views
1 citation

Opinion

Published on 16 Sep 2024

Cholesterol metabolism: a positive target to revoke the function of exhausted CAR-NK cells in tumor microenvironment

in Pharmacology of Anti-Cancer Drugs

Jingfeng Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1440869

1,363 views
1 citation

Review

Published on 16 Sep 2024

Roles of small peptides encoded by non-coding RNAs in tumor invasion and migration

in Pharmacology of Anti-Cancer Drugs

Jie Liu
Xiyue Chang
Laeeqa Manji
Zhijie Xu
Wan’an Xiao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1442196

999 views
2 citations

Review

Published on 16 Sep 2024

HER2-targeted therapies for HER2-positive early-stage breast cancer: present and future

in Pharmacology of Anti-Cancer Drugs

Luying Xu
Yuxin Xie
Qiheng Gou
Rui Cai
Rong Bao
Yucheng Huang
Ruisi Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1446414

4,829 views
4 citations

Review

Published on 16 Sep 2024

A comprehensive review on the potential of coumarin and related derivatives as multi-target therapeutic agents in the management of gynecological cancers

in Pharmacology of Anti-Cancer Drugs

Gökçe Şeker Karatoprak
Berrak Dumlupınar
Engin Celep
Inci Kurt Celep
Esra Küpeli Akkol
Eduardo Sobarzo-Sánchez

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1423480

7,836 views
10 citations

Systematic Review

Published on 13 Sep 2024

Research trends on chemotherapy induced nausea and vomiting: a bibliometric analysis

in Pharmacology of Anti-Cancer Drugs

Chunhui Ning
Yunzi Yan
Yansong Wang
Rui Li
Wenjie Liu
Linjie Qiu
Lingyun Sun
Yufei Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1369442

2,907 views
1 citation

Original Research

Published on 12 Sep 2024

Research hotspots and trends of epigenetic therapy in oncology: a bibliometric analysis from 2004 to 2023

in Pharmacology of Anti-Cancer Drugs

Sisi Li
Xinrui Liang
Qing Shao
Guanwen Wang
Yuxin Huang
Ping Wen
Dongping Jiang
Xiaohua Zeng

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1465954

2,052 views
1 citation

Systematic Review

Published on 12 Sep 2024

Mapping and visualization of global research progress on deubiquitinases in ovarian cancer: a bibliometric analysis

in Pharmacology of Anti-Cancer Drugs

Fang Qiu
Yuntong Li
Lile Zhou
Yingli Wu
Yunzhao Wu
Zhilei Fan
Yingying Wang
Dongjun Qin
Chaoqun Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1445037

2,257 views

Brief Research Report

Published on 12 Sep 2024

Overcoming drug resistance of cancer cells by targeting the FGF1/FGFR1 axis with honokiol or FGF ligand trap

in Pharmacology of Anti-Cancer Drugs

Jakub Szymczyk
Martyna Sochacka
Martyna Biadun
Katarzyna Dominika Sluzalska
Danuta Witkowska
Malgorzata Zakrzewska

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1459820

1,347 views

Systematic Review

Published on 12 Sep 2024

Adjuvant and neoadjuvant therapy with or without CDK4/6 inhibitors in HR+/HER2- early breast cancer: a systematic review and meta-analysis

in Pharmacology of Anti-Cancer Drugs

Zhihao Zhang
Xin Zhao
Jie Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1438288

2,542 views

Original Research

Published on 11 Sep 2024

Network pharmacology and transcriptomics reveal the mechanisms of FFBZL in the treatment of oral squamous cell carcinoma

in Pharmacology of Anti-Cancer Drugs

Shiyang Zhao
Shudong Xiao
Wanting Wang
Xinyue Dong
Xichen Liu
Qingsen Wang
Yourong Jiang
Wen Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1405596

2,760 views
1 citation

Mini Review

Published on 09 Sep 2024

Novel role of circRNAs in the drug resistance of gastric cancer: regulatory mechanisms and future for cancer therapy

in Pharmacology of Anti-Cancer Drugs

Ling Lu
Zihan Gao
Longtao Jin
Hao Geng
Zhaofeng Liang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1435264

1,616 views
3 citations

Original Research

Published on 06 Sep 2024

The lncRNA CADM2-AS1 promotes gastric cancer metastasis by binding with miR-5047 and activating NOTCH4 translation

in Pharmacology of Anti-Cancer Drugs

Yu-Tong Zhang
Li-Juan Zhao
Teng Zhou
Jin-Yuan Zhao
Yin-Ping Geng
Qiu-Rong Zhang
Pei-Chun Sun
Wen-Chao Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1439497

1,474 views